Slingshot members are tracking this event:

Galapagos (GLPG) Doses First Patient in Phase 2 EQUATOR Study Evaluating Filgotinib in Psoriatic Arthritis

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 05, 2017
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords First Patient Dosing, Phase 2, Equator, Filgotinib, Psoriatic Arthritis